These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33963415)

  • 1. Academic application of Good Cell Culture Practice for induced pluripotent stem cells.
    Tigges J; Bielec K; Brockerhoff G; Hildebrandt B; Hübenthal U; Kapr J; Koch K; Teichweyde N; Wieczorek D; Rossi A; Fritsche E
    ALTEX; 2021; 38(4):595-614. PubMed ID: 33963415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Banking of hiPSCs: A Practical Guide to Cryopreservation and Quality Control in Basic Research.
    Shibamiya A; Schulze E; Krauß D; Augustin C; Reinsch M; Schulze ML; Steuck S; Mearini G; Mannhardt I; Schulze T; Klampe B; Werner T; Saleem U; Knaust A; Laufer SD; Neuber C; Lemme M; Behrens CS; Loos M; Weinberger F; Fuchs S; Eschenhagen T; Hansen A; Ulmer BM
    Curr Protoc Stem Cell Biol; 2020 Dec; 55(1):e127. PubMed ID: 32956561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells.
    Shafa M; Walsh T; Panchalingam KM; Richardson T; Menendez L; Tian X; Suresh Babu S; Dadgar S; Beller J; Yang F; Baghbaderani BA
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.
    Rao MS; Pei Y; Garcia TY; Chew S; Kasai T; Hisai T; Taniguchi H; Takebe T; Lamba DA; Zeng X
    Cytotherapy; 2018 Jun; 20(6):861-872. PubMed ID: 29793831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan 3D cell culture system promotes naïve-like features of human induced pluripotent stem cells: A novel tool to sustain pluripotency and facilitate differentiation.
    Chang PH; Chao HM; Chern E; Hsu SH
    Biomaterials; 2021 Jan; 268():120575. PubMed ID: 33341735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017.
    Kim JH; Alderton A; Crook JM; Benvenisty N; Brandsten C; Firpo M; Harrison PW; Kawamata S; Kawase E; Kurtz A; Loring JF; Ludwig T; Man J; Mountford JC; Turner ML; Oh S; da Veiga Pereira L; Pranke P; Sheldon M; Steeg R; Sullivan S; Yaffe M; Zhou Q; Stacey GN
    Stem Cells; 2019 Sep; 37(9):1130-1135. PubMed ID: 31021472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalable stirred suspension culture for the generation of billions of human induced pluripotent stem cells using single-use bioreactors.
    Kwok CK; Ueda Y; Kadari A; Günther K; Ergün S; Heron A; Schnitzler AC; Rook M; Edenhofer F
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e1076-e1087. PubMed ID: 28382727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality Assurance in Stem Cell Banking: Emphasis on Embryonic and Induced Pluripotent Stem Cell Banking.
    Kallur T; Blomberg P; Stenfelt S; Tryggvason K; Hovatta O
    Methods Mol Biol; 2017; 1590():11-16. PubMed ID: 28353259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
    Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
    PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.
    Baghbaderani BA; Syama A; Sivapatham R; Pei Y; Mukherjee O; Fellner T; Zeng X; Rao MS
    Stem Cell Rev Rep; 2016 Aug; 12(4):394-420. PubMed ID: 27283945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease.
    Ribeiro PC; Lojudice FH; Fernandes-Charpiot IMM; Baptista MASF; de Almeida Araújo S; Mendes GEF; Sogayar MC; Abbud-Filho M; Caldas HC
    Stem Cell Res Ther; 2020 Dec; 11(1):530. PubMed ID: 33298161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.
    Ausubel LJ; Lopez PM; Couture LA
    Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
    Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
    Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Authentication and banking of human pluripotent stem cells.
    Josephson R; Auerbach J
    Curr Protoc Stem Cell Biol; 2009 Dec; Chapter 1():Unit 1C.9. PubMed ID: 19960451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Korea National Stem Cell Bank.
    Kim JH; Jo HY; Ha HY; Kim YO
    Stem Cell Res; 2021 May; 53():102270. PubMed ID: 33714852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells.
    Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB
    Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.
    Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS
    Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep-learning-based multi-class segmentation for automated, non-invasive routine assessment of human pluripotent stem cell culture status.
    Piotrowski T; Rippel O; Elanzew A; Nießing B; Stucken S; Jung S; König N; Haupt S; Stappert L; Brüstle O; Schmitt R; Jonas S
    Comput Biol Med; 2021 Feb; 129():104172. PubMed ID: 33352307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Research-Grade Human Induced Pluripotent Stem Cells Qualification and Biobanking Processes.
    Ntai A; Baronchelli S; La Spada A; Moles A; Guffanti A; De Blasio P; Biunno I
    Biopreserv Biobank; 2017 Aug; 15(4):384-392. PubMed ID: 28388226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells.
    Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA
    Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.